Day One Biopharmaceuticals Inc (DAWN) financials · rev $158.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Day One Biopharmaceuticals Inc (DAWN) rev $158.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $158.2M | $131.2M |
| Operating Income | -$127.8M | -$217.3M |
| Net Income | -$107.3M | -$95.5M |
| EPS (Diluted) | -$1.04 | -$1.02 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $507.8M | $582.8M |
| Current Assets | $485.1M | $562.3M |
| Cash & Equivalents | $197.1M | $125.0M |
| Inventory | $6.33M | $3.32M |
| PP&E | $2.14M | $2.29M |
| Total Liabilities | $66.7M | $80.0M |
| Current Liabilities | $60.5M | $73.5M |
| Shareholders' Equity | $441.2M | $502.8M |
| Retained Earnings | -$661.4M | -$554.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$103.8M | -$78.1M |
| CapEx | $320.0K | $2.17M |
| Investing Cash Flow | $174.6M | -$231.0M |
| Financing Cash Flow | $1.22M | $203.3M |
| Free Cash Flow | -$104.1M | -$80.3M |
FAQ
What is DAWN P/E and revenue?
Day One Biopharmaceuticals Inc (DAWN) rev $158.2M.
What is DAWN revenue?
Day One Biopharmaceuticals Inc last cached revenue is $158.2M (FY2025).
Is DAWN profitable?
Day One Biopharmaceuticals Inc last cached net income is -$107.3M (FY2025).
What are DAWN total assets?
Day One Biopharmaceuticals Inc last cached total assets are $507.8M (FY2025).
What is DAWN free cash flow?
Day One Biopharmaceuticals Inc last cached free cash flow is -$104.1M (FY2025).
Not investment advice. Cached statements, not a live tape.